The global biotechnology market reached a size of USD 761.5 Billion in 2024 and is expected to grow to USD 1,315.9 Billion by 2033. The market is projected to expand at a CAGR of 6.27% from 2025 to 2033. This growth is driven by increased R&D in personalized medicine, advancements in genetic engineering, and growing demand for sustainable agriculture. 

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Biotechnology Market Key Takeaways

• Current Market Size: USD 761.5 Billion in 2024
• CAGR: 6.27% during 2025-2033
• Forecast Period: 2025-2033
• The market is propelled by rapid advancements in genetic engineering, including CRISPR-Cas9 technology, enhancing genetic modifications for medical and agricultural uses.
• Increasing demand for personalized medicine and therapeutics drives growth, supported by genomic sequencing technologies and production of biopharmaceuticals.
• Rising need for sustainable agriculture solutions fuels adoption of genetically modified crops and biopesticides that reduce environmental impact.
• The integration of bioinformatics optimizes R&D processes, enhancing information-driven biotechnology developments.
• Establishment of bioremediation technologies and biofuels due to environmental sustainability concerns further drives market expansion.

Sample Request Link: 

https://www.imarcgroup.com/biotechnology-market/requestsample

Market Growth Factors

The biotechnology market's growth is primarily driven by rapid advancements in genetic engineering. Technologies like CRISPR-Cas9 enable precise gene modification in organisms, expanding applications across medicine, agriculture, and industrial processes. Genetic engineering contributes to innovative gene therapies targeting genetic disorders and cancers and supports microbial production of valuable compounds such as insulin and enzymes, transforming pharmaceutical and industrial manufacturing sectors.

The increasing demand for personalized medicine and therapeutics significantly propels the biotechnology market. Advancements in genomic sequencing allow detailed analysis of genetic codes, enabling the development of targeted therapies tailored to individual genetic makeup. This enhances treatment efficacy and safety. Production of biopharmaceuticals like monoclonal antibodies and gene therapies aligns with personalized medicine principles, while diagnostics based on genetic markers enable early disease detection and prognosis.

Sustainable agriculture solutions are increasingly critical due to rising global food demand and environmental concerns. Biotechnology offers genetically modified crops engineered for higher yield, pest resistance, and improved nutrition. Biopesticides, derived from natural organisms, offer eco-friendly alternatives to chemical pesticides. Biotechnology also supports optimizing plant traits, enhancing resilience to climate change, and improving nutrient efficiency, contributing to food security and resource sustainability.

Market Segmentation

Breakup by Product Type:

• Instruments: Serve as essential tools for advanced research and diagnostics, facilitating precise experimentation and analysis.
• Reagents: Fundamental components that drive experimental processes and enable accurate results.
• Software and Services: Include data analysis, visualization, integration, consulting, training, and technical support, enhancing efficiency and collaborative biotechnological development.

Breakup by Technology:

• Nanobiotechnology: Combines nanoscale materials with biological systems, advancing drug delivery, diagnostics, and therapies.
• Tissue Engineering and Regeneration: Develops functional tissues to address organ shortages and medical needs.
• DNA Sequencing: Enables comprehensive genomic analysis for personalized medicine and disease understanding.
• Cell-Based Assays: Offers insights into cellular behavior for drug development and toxicity testing.
• Fermentation: A fundamental bioprocess producing biofuels, pharmaceuticals, and enzymes.
• PCR Technology: Amplifies DNA, supporting diagnostics and genetic research.
• Chromatography: Precisely separates biomolecules, crucial for drug purification and analytics.
• Others

Breakup by Application:

• Healthcare: The largest segment, driving innovations in diagnostics, treatment development, and personalized medicine through biotechnology.
• Food and Agriculture: Incorporates genetic modifications and biopesticides to improve food production and sustainability.
• Natural Resources and Environment
• Industrial Processing
• Bioinformatics
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Regional Insights

North America dominates the biotechnology market, credited to its robust ecosystem of research, innovation, and industry collaboration. The region benefits from strong R&D investment and well-established regulatory frameworks fostering breakthroughs. It also shows a rising emphasis on entrepreneurship and venture capital, accelerating commercialization of biotech solutions. For instance, North Carolina’s strong biopharma manufacturing and agricultural biotech innovations highlight the region’s growth and leadership in biotechnology.

Recent Developments & News

In May 2025, Biogen and City Therapeutics partnered to develop RNA interference (RNAi) therapies targeting central nervous system diseases, with Biogen leading clinical development and commercialization. Biocon Biologics launched a biosimilar, Ustekinumab BS Subcutaneous Injection [YD], in Japan. Novartis announced a USD 23 Billion investment over five years in the US for biotech and pharmaceutical expansion. Amgen committed USD 900 Million to expand its Ohio biologics manufacturing site. In March 2025, Roche opened the Roche Genentech Innovation Center Boston to lead R&D in cardiovascular, renal, and metabolism diseases, supporting AI-driven drug discovery.

Key Players

• Amgen Inc.
• Biocon Limited
• Biogen Inc.
• F. Hoffmann-La Roche AG
• Genmab A/S
• Lonza Group AG
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Seagen Inc.
• Syngenta AG
• Vertex Pharmaceuticals Incorporated

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5785&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302